Medical Devices; General and Plastic Surgery Devices; Classification of the Software-Aided Adjunctive Diagnostic Device for Use by Physicians on Lesions Suspicious for Skin Cancer
Federal Register notice from the Federal Register
Headline as published by Federal Register: FDA on Oct 30, 2026; collected by the wire Oct 30, 2026, 3:31 AM ET.
The Food and Drug Administration (FDA) is classifying the software-aided adjunctive diagnostic device for use by physicians on lesions suspicious for skin cancer into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the software-aided adjunctive diagnostic device for use by physicians on lesions suspicious for skin cancer. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and…
Coverage
Named in this story
- AgencyU.S. Food and Drug AdministrationMatched on
Food and Drug Administration
Topics
- Drugs and medical devicesMatched on
Medical Devices
Explore the named firms, organizations and MDL dockets above. Sources and method